Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding study of HR18042 for pain after impacted tooth extraction
CTR20221838Phase 2Terminated
- Sponsor
- Hengrui Therapeutics
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HR18042 in postoperative pain, sponsored by Hengrui Therapeutics. Started Aug 2022; status: terminated.
02
Drugs
HR18042
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20221838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221838.